NCT06132529View on ClinicalTrials.gov

A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache

CompletedOBSERVATIONAL
Enrollment

151

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Post-Traumatic HeadacheHealthy
Interventions
DIAGNOSTIC_TEST

Brain Magnetic Resonance Imaging (MRI) Scan

Imaging of the brain

OTHER

Speech Sample

Recorded reading aloud of pre-written words and sentences

OTHER

Electronic Daily Headache Diary

Headache diary to provide information about headaches experience that day.

Trial Locations (2)

85012

VA Health Care System, Phoenix

85054

Mayo Clinic Arizona, Phoenix

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Arizona State University

OTHER

lead

Mayo Clinic

OTHER

NCT06132529 - A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache | Biotech Hunter | Biotech Hunter